Therefore, ABCG2-high pancreatic CSCs might be well targeted by 5-ALA PDT using an ABCG2 inhibitor, and this approach could be another way to target SHH signaling-activated pancreatic cancer cells. This evidence concerns the gene SHH and pancreatic neoplasm.